Department of Immunology, Nara Medical University, Kashihara 6348521, Japan.
Department of Anesthesiology, Nara Medical University, Kashihara 6348521, Japan.
Int J Mol Sci. 2023 Nov 12;24(22):16230. doi: 10.3390/ijms242216230.
Acute respiratory distress syndrome (ARDS) has no specific and effective treatment, and there is an urgent need to understand its pathogenesis. Therefore, based on the hypothesis that molecules whose expression is upregulated in injured pulmonary vascular endothelial cells (VECs) are involved in the pathogenesis of ARDS, we conducted a study to elucidate the molecular mechanisms and identify target factors for treatment. Primary human lung microvascular endothelial cells (HMVEC-Ls) were stimulated with lipopolysaccharide (LPS) or poly (I:C) and analyzed via a microarray to identify target genes for ARDS. We found that a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS4) was induced in murine lung VECs in an LPS-mediated ARDS model. Elevated ADAMTS4 was also observed by the immunostaining of lung samples from ARDS patients. The suppression of ADAMTS4 by siRNA in VECs ameliorated LPS-stimulated vascular permeability. The impairment of the cell surface expression of syndecan-1, a marker of the glycocalyx that is an extracellular matrix involved in vascular permeability, was dramatically inhibited by ADAMTS4 suppression. In addition, the suppression of ADAMTS4 protected against LPS-induced reductions in syndecan-1 and the adherens junction protein vascular endothelial cadherin. These results suggest that ADAMTS4 regulates VEC permeability in ARDS and may be a predictive marker and therapeutic target for ARDS.
急性呼吸窘迫综合征(ARDS)尚无特异性和有效的治疗方法,因此迫切需要了解其发病机制。基于损伤的肺血管内皮细胞(VEC)中表达上调的分子参与 ARDS 发病机制的假说,我们进行了一项研究,以阐明分子机制并确定治疗的靶因子。用脂多糖(LPS)或聚(I:C)刺激原代人肺微血管内皮细胞(HMVEC-L),并通过微阵列分析鉴定 ARDS 的靶基因。我们发现,在 LPS 介导的 ARDS 模型中,鼠肺 VEC 中诱导了一种带有血小板反应蛋白基序的解整合素金属蛋白酶 4(ADAMTS4)。ADAMTS4 的升高也通过 ARDS 患者肺样本的免疫染色观察到。在 VEC 中用 siRNA 抑制 ADAMTS4 可改善 LPS 刺激的血管通透性。ADAMTS4 抑制可显著抑制糖萼的标志物(参与血管通透性的细胞外基质)表面蛋白硫酸乙酰肝素聚糖 1 的细胞表面表达受损。此外,ADAMTS4 的抑制可防止 LPS 诱导的硫酸乙酰肝素聚糖 1 和黏着连接蛋白血管内皮钙黏蛋白的减少。这些结果表明,ADAMTS4 调节 ARDS 中的 VEC 通透性,可能是 ARDS 的预测标志物和治疗靶标。